Search results
Results from the WOW.Com Content Network
South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.
The third Health Sector Strategic Plan (HSSP-III) [15] is a framework document for the development and shaping of health policy in Rwanda. Among its goals are the reduction of HIV infections, reduction of HIV-related morbidity and mortality, strengthened management of HIV/AIDS and equal opportunities for people living with HIV.
This template should not be used directly. It is used indirectly by flag templates such as Template:Flag and Template:Flag icon. See Category:Flag template system for a full list of flag templates and Wikipedia:WikiProject Flag Template for further documentation. Template parameters [Edit template data] Parameter Description Type Status No parameters specified This is the documentation for ...
The roughly 375 medicine manufacturers on the continent produce only 10-30% of drugs used in Africa. [7] Another challenge is the proliferation of substandard and counterfeit medical products. [ 8 ] Porous borders make it easy for such products to move within the continent, and there is significant variation in the quality of current medical ...
Health insurance became mandatory for all individuals in 2008; [5] in 2010 over 90% of the population was covered. [6] In 2012, only about 4% were uninsured. [1]President Kagame made healthcare one of the priorities for the Vision 2020 development programme, [7] boosting spending on health care to 6.5% of the country's gross domestic product in 2013, [8] compared with 1.9% in 1996. [9]
This program covers all low- and middle-income countries, as well as all of Sub-Saharan Africa. [ 7 ] The company has also granted voluntary licenses to 14 generics companies to enable the low-cost manufacture and sale of generic versions of the company's products in specific countries and/or regions.
Rwanda, Senegal, and South Africa were identified as countries where mRNA vaccines might be produced. Africa CDC aims to have 60% of vaccines used in Africa be produced in Africa by 2040, as opposed to less than 1% in 2021. [13] An African Epidemics Fund was agreed to in a February 2022 meeting.
The National Forensic DNA Database of South Africa (NFDD) is a national DNA database used in law enforcement in South Africa.The Criminal Law (Forensic Procedures) Amendment Act No. 37 of 2013 (the "DNA Act") provides for the expansion and administration of such a database in South Africa, enabling the South African Police Service (SAPS) to match forensic DNA profiles derived from samples ...